When the Imaging system is paired with the Influenza Seasonal Hemagglutinin potency assay kit ... It can be used at any stage in the vaccine manufacturing process. Disclaimer: AAAS and EurekAlert!

The concept of using vaccines to treat cancers has been around for several decades. A vaccine was first approved for prostate cancer in 2010, and another was approved in 2015 for melanoma. Since then, ...

The history of sipuleucel-T illustrates a number of the challenges for developers of cancer vaccines. The company recognized at an early stage that a robust potency assay for the effects of ...

The Inaugural Gene Therapy Potency Summit (August 29-31) is dedicated to providing you with tools to identify, characterize and measure potency, enabling you to take tactical insights back to your ...

NiV&HeV: A New Era of Structure-based Vaccine Design? Nipah virus (NiV ... using SEC-MALS and their high activity was further confirmed through ELISA or SPR assays. These antigens are ideal for ...

For these therapies to gain regulatory approval, it's crucial to have robust potency assays in place, making it paramount that an effective potency design is incorporated into every drug developer ...